Background-The infant gut's ability to suppress immunologic reactions to food proteins could be influenced by levels of TGFβ in breast milk. We hypothesized that lower levels of TGFβ 1 in the breast milk (BM) of mothers in the WHEALS birth cohort are associated with atopy at infant age 2-3 years.
Introduction
Much is unknown about the development of food allergies during infancy. 1 Current research suggests that variation in the risk of developing food allergy is linked to the infant gut's ability to develop oral tolerance. 2 Oral tolerance refers to the immune system's selfsuppression of immunologic reactions to food proteins. 3 Breast milk is often the first food to which infants are exposed. 4, 5 The benefits of breast feeding include transmission of Immunoglobulin A (IgA). 6 IgA works in conjunction with TGFβ and other cytokines postulated to play an important role in the development of oral tolerance. 7 TGFβ is a polypeptide that regulates cell growth through exerting both stimulatory and inhibitory effects on a variety of cell types. 8 Three isoforms of this cytokine are expressed in humans, two of which are found in human milk (TGFβ 1 and TGFβ 2 ). 8 TGFβ and interleukin 10 (IL10) have been shown to affect IgA production (3) and mediate other parts of the mucosal immune system. Production of TGFβ in gut lymphoid tissue acts to maintain tolerance to benign gut pathogens and food allergens by downregulating inflammatory cytokines, and working with IL10 to promote IgA production. 3 Because TGFβ is integral to infant gut immunity, it has been suggested that levels of this and other cytokines in breast milk may explain the lack of consistent findings in studies investigating the association of breast feeding to risk of food allergy, i.e., some studies have reported a reduced risk of atopy with breast feeding, while others have reported no association or increased risk. [9] [10] [11] One hypothesis is that lower levels of these cytokines in breast milk may confer a greater risk of atopy developing in the infant. 12, 13 To our knowledge, this hypothesis has not been explored by race. We explored the relationship between atopic manifestations and levels of TGFβ 1 in the breast milk of mothers who participated, along with their infants, in the WHEALS birth cohort. We hypothesized that lower levels of TGFβ 1 in the breast milk of mothers enrolled in the cohort would be associated with the following in the infant (1) prevalence of egg, milk, or peanut allergy; (2) specific IgE to egg, milk, or peanut; and/or (3) a positive skin prick test to egg, milk, or peanut.
Methods & Materials Eligibility
All aspects of this research were approved by institutional review boards responsible for the conduct of research in human subjects at Henry Ford Health System (HFHS) and Georgia Regents University. The overall objective of the WHEALS cohort is to identify environmental factors, especially pet exposures, related to the development of allergy and asthma in infancy and childhood. 14 The WHEALS cohort comprises pregnant women aged 21-45 years who were seen for prenatal care in one of five HFHS obstetric clinics between 9/1/2003 and 11/26/2007, resided in the city of Detroit or Detroit western suburbs as defined by zip code, spoke English well enough to provide written informed consent, and had plans to stay in the Detroit area for two years after delivery.
Recruitment
Recruitment for the WHEALS birth cohort is described in previous publications. 15 Potentially eligible women were identified using a centralized automated appointment scheduling system. Each woman was sent a study introduction letter within two weeks of her mid-third trimester appointment, and was approached in the waiting room prior to her appointment by a trained recruiter, who obtained written informed consent if the woman was interested in participating. Eligibility was not based on maternal or family history of allergy or asthma.
Home and clinic visits
Home visits were conducted at infant age 1, 6, and 12 months by research staff. At child age 2-3 years, clinic visits were conducted by HFHS staff physicians and nurses trained in the study protocol. During this visit, a venous blood sample was collected from the child for measuring total and specific IgE to milk, egg, and peanut allergen.
Collection of information on breast feeding and measurement of TGFβ in breast milk
At the 1, 6, and 12-month home visits, mothers were asked about breast feeding practices and duration of breast feeding. At the one-month visit, breast milk specimens were collected by those participants that were currently breast feeding.
A sterilized disposable breast pump kit (Medela Classic) was used to collect 2 ounces of breast milk from each participant. For each 2 ounce sample, 3 × 1 ml aliquots of breast milk were transferred into 3 sterile cryovials using a sterile pipette. The breast milk samples were placed on ice until delivery to the Department of Public Health Sciences lab where the remaining breast milk was centrifuged at 4°C to separate the lipid and aqueous fractions. After removal of the lipid layer, 3 × 1 ml aliquots of the aqueous fraction were transferred into cryovials and the whole milk, lipid layer and aqueous fractions were stored at −80°C. The aqueous fraction was utilized for assay of cytokines. TGFβ 1 was assayed using commercial ELISA kits (R&D Systems, Minneapolis, MN) according to manufacturer instructions.
Concentration of Allergen-specific IgE
Total and allergen specific IgE (sIge) measurements in plasma collected at 2-3 years of age were performed using the Phadia UniCAP system (Phadia, Thermo Fisher Scientific, Inc., Waltham, MA). Total serum IgE concentrations were measured using the UniCAP low range protocol (0.1-100 IU/ml). Samples with IgE > 70 IU/ml were diluted as necessary and reassayed to obtain a valid measurement. As this paper focuses on food allergy, samples included in this analysis were tested for IgE antibodies to milk, egg, and peanut allergens. Infant seratopy to food allergens was defined as sIgE ≥ 0.35 IU/ml to egg, milk or peanut. Mother's blood samples were analyzed for specific IgE to 8 allergens: egg white, Dermatophagoides farinae, cat, dog, cockroach, ragweed, timothy grass, and Alternaria alternata. Mother's seratopy was defined as a specific IgE ≥ to 0.35 IU/ml to one or more of these allergens.
Skin prick test
Skin prick testing was performed in children without contraindications by the puncture method on the volar surfaces of the forearm using a Duotip-test® device (Lincoln Diagnostics, Inc., Decatur, IL) and using commercial extracts. Allergens tested included egg, milk, peanut, dog, cat, cockroach, short ragweed, grass, Alternaria, and two dust mite species (D. pteronyssinus and D. farinae). A negative saline control and a positive histamine control (1 mg/ml) were included with all tests. Fifteen minutes after the skin tests were placed; the resulting wheal and flare responses were measured at the longest diameter and recorded. A positive skin prick test (SPT+) was defined as one producing a wheal with a diameter of at least 3mm larger than the negative control. 16 
Determination of food allergy
We used a physician panel to classify cohort participants as to the presence or absence of IgE-mediated food allergy (FA) to milk, peanut and egg. The physician panel, two boardcertified allergists, classified infants as "Highly Probable", "Likely" and Unlikely" for IgEmediated food allergy. A third allergist was consulted for discordant reviews. The physician panel was presented with data collected from the parent interview (including information on infant gastrointestinal illnesses suggestive of food intolerance or food allergy, other potential allergic reactions such as rash or colic, and any report of food avoidance) as well as information from clinical assessments (serum total and sIgE and SPT results). Infants were selected for physician panel review if they met at least one of the following three criteria: 1) possessed at least one food-specific IgE ≥ 0.35 IU/ml; 2) possessed a positive SPT (i.e., wheal 3mm or greater than the control); or 3) possessed food allergy-related symptoms/food avoidance (i.e., occurrence of rash, wheeze, hives, vomiting, diarrhea, pruritus, abdominal pain etc., attributed to food ingestion) plus at least one food-specific IgE ≥ 0.10 IU/ml. The latter criterion was set low purposefully to ensure that the records of all participants with a remote possibility of food allergy were included for physician review. Panelists reviewed (1) cord blood IgE measures; (2) parent interviews at 1, 6, 12, and 24 months, including family history of asthma/allergy; (3) a 36-month parent interview including items on food avoidance, gastrointestinal symptoms, onset and duration of reactions to food; (4) infant medical records; and (5) allergen-specific IgE and skin prick test results at 24 months. Children classified as "Highly Probable" or "Likely" for IgE-mediated FA were included in this analysis.
Statistical Analysis
The study population for these analyses includes cohort children with 1-month breast milk samples, 6 or 12-month interview data, data from the clinic visit at 2-3 years, and specific IgE measures at 2-3 years. For this analysis, atopic phenotypes included FA as determined by physician panel, allergen-specific IgE to egg, milk, or peanut (spIgE) and SPT+ to egg, milk, or peanut. Chi-square tests were used to make subgroup comparisons of participant characteristics for binary and categorical variables, and Student's t-tests were used for comparison of continuous variables.
Due to skewness of the data, cytokine levels were compared with the Wilcoxon Rank Sum (WRS) test. Geometric means (GM) and 95% confidence intervals (95% CI) are presented for descriptive purposes. TGFβ 1 values were log-transformed prior to inclusion in any model. To assess interaction, we used a logistic regression model for each atopic phenotype where the log-transformed TGFβ 1 values and the variable of interest (infant race or mother's atopic status), along with the interaction term, was entered. A p-value < 0.10 was used to indicate the presence of an interaction. 17 Logistic regression was used to calculate odds ratios (OR) and corresponding 95% CIs to describe the association between TGFβ 1 concentrations (pg/ml) and atopic phenotype after controlling for potential confounders. Independent variables reported at predelivery included yearly household income < $40,000, maternal education ≤ High school, and marital status. In addition, from the 1 and 6 month survey, we collected mother's report of infant race, infant gender, breastfeeding < 6 months, infant exposure to environmental tobacco smoke during mother's pregnancy, and current smoking in child's household. Independent variables were retained in the final model if their inclusion changed the estimate of effect between atopic phenotype and TGFβ 1 by more than 15%. 18 
Results
Of the 800 participants completing the 2 year clinic visit, 620 reported breast-feeding, of which 304 had data sufficient for analysis (Figure 1) . Prevalence of FA in the cohort was 7.9% (n=24) according to classification by physician panel review. Table 1 is a comparison of cohort members included and excluded from the study sample. Those included in the analysis did not significantly differ in terms of maternal history of asthma, but did differ with regard to factors already shown to be related to breast feeding, including race, 19 maternal age, 20 maternal education, 20 socioeconomic status, 19 and smoking. 21 Table 2 shows the characteristics of the study population by mother's report of infant race. Black mothers were significantly younger, less likely to be married, had less education, lower incomes, were less likely to breastfeed for ≥ 6 months, and were more likely to reside with a smoker (Table 2) . Table 3 shows TGFβ 1 levels in breast milk, by infant race and maternal atopy, and by whether or not the infant met criteria for FA, spIgE, or was SPT+ to egg, milk, or peanut. TGFβ 1 levels in the breast milk of mothers were significantly higher for Black infants (geometric mean = 2027pg/ml vs. 1394pg/ml, p<0.001) and atopic mothers (1813 pg/ml vs. 1509 pg/ml, p=0.007). Overall, levels of TGFβ 1 in breast milk were not significantly different for infants who were determined by physician panel review to have FA, had specific IgE to egg, milk or peanut ≥ 0.35 IU/ml, or had a positive skin prick test to any of these three food allergens. Table 4 shows the relationship of TGFβ 1 levels in breast milk and atopic phenotype stratified by infant race/ethnicity and maternal atopy. Among non-Black infants, TGFβ 1 levels in breast milk were lower for those classified as FA (p=0.081) and for SPT+ to food allergens (p=0.064). Maternal atopy also seemed to modify the relationship between breast milk TGFβ 1 level and infant risk of atopy (Table 4) . Among mothers with atopy, TGFβ 1 levels in breast milk were positively related to her child having specific IgE to egg, milk or peanut (p=0.001). However, among non-atopic mothers, levels of TGFβ 1 in breast milk were lower for sensitized infants compared to non-sensitized infants (p=0.047). Although not significant, this pattern was also observed for infants who were classified as FA and who had positive skin prick tests.
Multivariate analyses
We observed interactions between infant race and TGFβ 1 (p=0.046) and maternal atopy and TGFβ 1 (p=0.064) on FA; also, between mother's atopy status and TGFβ 1 (p=0.001) on spIgE. Based on this assessment, we created strata that included both mother's atopy status and child's race and ran logistic regression models for each of the atopic indicators (Table  5 ). For the three atopic indicators, a pattern emerged similar to that observed for bivariate analyses. Elevated odds ratios for the association between levels of TGFβ 1 in breast milk and indicators of atopy in the infants of atopic, Black mothers were observed (adjusted OR=2.30 and 2.22, respectively, for FA and spIgE, p=0.12 and p=0.067.) If mother was atopic, but infant was non-Black, results suggested an inverse relationship between TGFβ 1 levels in breast milk and FA, but a positive relationship between TGFβ 1 and spIgE. For nonatopic mothers of non-Black infants, results suggest that TGFβ 1 levels in breast milk may be inversely related to food sensitization in the infant at age 2-3 years. Adjusted ORs were consistently less than 1.0 for FA, spIgE, and SPT+, although ORs did not reach conventional levels of statistical significance. Using the BM TGFβ 1 values categorized as tertiles, as done in a previously published paper by Oddy et al, did not change the results of this analysis. 13 
Discussion
We explored the association of TGFβ 1 in breast milk to risk of atopic manifestations in the breast-fed infant by age 2-3 years. We hypothesized that low TGFβ 1 levels in breast milk would be positively associated with evidence of atopy by age 2-3 years. We found that race and mother's atopic status were strong effect modifiers of this relationship. Evidence in support of our hypothesis was found only among non-atopic mothers with non-Black infants. Consistent differences by race for risk factors of asthma and allergy have been reported. [22] [23] [24] [25] [26] Clearly, identifying the social or biological factors associated with infant race that can impact immune function and regulation will be key to determining the mechanisms by which the risk of asthma and allergy is modulated in Black individuals.
Currently, there is no consensus on the relationship of breast feeding and risk of atopy in the infant. 1 The composition of breast milk varies considerably between mothers and is influenced by maternal atopy. 27, 28 In a systematic review published by Oddy et al., allergic status of the mother was one of several factors that influenced the measured concentrations of TGFβ 1 , in addition to maternal diet, local infection, and genetic factors. 1 Some patterns observed in this analysis, to our knowledge, have not appeared in the literature. In 2003, Oddy et al. examined the relationship between infant wheeze and measures of TGFβ and IL10, among other cytokines, in the breast milk of 243 mothers enrolled in the Infant Immune Study, and found an inverse relationship between TGFβ 1 and risk of infant wheeze (p=0.006, trend Χ 2 ). 13 Similar results have been reported in Finland high-risk cohorts, 5, 29 although Bottcher et al found that composition of cytokines, chemokines and sIgA in mothers' breast milk did not influence the risk of atopy by age 2 years. 30 According to the Oddy review, of 8 of 12 human studies investigating TGFβ in breast milk demonstrated an inverse association between TGFβ 1 or TGFβ 2 and allergic manifestations in early childhood or infancy. 1 In our study, breast milk TGFβ 1 was significantly higher in atopic mothers, but this is in contrast to some previous reports. Rigotti et al., found that TGFβ 1 was significantly less secreted in mature milk of allergic mothers. 31 Laiho, in 2003, reported lower concentrations of TGFβ 2 in mothers with atopic dermatitis than in mothers without atopic dermatitis. 32 A study done in the Czech Republic did not find significant differences in TGFβ by mother's allergic status. 33 All of these studies had relatively small sample sizes and contained only White subjects.
There are several limitations to our analysis. We included only participants who reported breast feeding and for whom a breast milk sample was available for processing. Race, education, smoking and income are highly related to the decision to breast feed. For this reason, our results apply only to those mother-infant pairs with characteristics similar to the cohort participants in this analysis. These relationships should be explored in other birth cohorts by race and maternal atopy status. In addition, we did not collect colostrum. In the few studies that have included colostrum, trends have not been found to be significantly different from those observed in mature breast milk. 29, 33 We were also unable to examine associations by individual foods due to small cell sizes. We know from previous analyses that risk of food sensitization may vary by allergen, 25, 26 and therefore variations in exposure to breast milk cytokines may influence risk of atopy differently for different allergens. Finally, a larger sample would have allowed better point estimates, given that we identified maternal atopy and Black infant race as effect modifiers of the associations of interest.
In summary, we explored an association between the level of TGFβ 1 in breast milk and several atopic phenotypes in infants. Certainly, more research is needed in this area especially with regard to infant race/ethnicity and mother's atopic status. Exploring level of TGFβ 1 in breast milk and infant atopy may elucidate mechanisms for incidence of FA. Knowledge of an immune benefit to infants of TGFβ 1 in breast milk could contribute to the development of protective strategies or interventions designed to prevent atopy in children.
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